/api/archive/snapshots/cc4bafeccad04d426111990fa5351c4a7945cdebfaa01dbb7f4a545d13953bb0/page.html
View dossier →Jonah Dallas Yakel alias The Mold Laundry List
TikTok · 6922559673934480390
Practice location
11791 W 112TH ST
OVERLAND PARK, KS 66210
Persuasion and sales-funnel patterns outweigh the evidence here.
- Of 14 health claims, 5 run counter to or conflict with the published evidence, and 9 were not independently checked.
- Primary persuasion tactic: Disease-dump hashtag stack.
- Stated credentials look inflated relative to the advice given.
- Gives advice beyond what their license covers.
Jonah Yakel is serving the classic chronic-illness buffet: a little mold, a little CIRS, then a sprinkle of depression, anxiety, ADHD, Alzheimer’s, dementia, fibromyalgia, and chronic fatigue for maximum algorithmic bait. It’s the sort of broad-spectrum scare branding that makes everyone feel like a root-cause breakthrough is one consult away.
Elevated grift signals
Score breakdown
Direct answer
Jonah Dallas Yakel is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.S.A. §65-2871 (Kansas Healing Arts Act)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating CIRS, depression, ADHD, Alzheimer's, and dementia, conditions that belong with appropriately board-certified physicians. Those same pages route patients toward paid programs that Jonah Dallas Yakel profits from.
Key findings
- Cherry-Picked Evidence: The post bundles a long list of serious, overlapping conditions into a single hashtag cloud. That is classic reach-maximizing and trust-borrowing: it signals that the creator wants to be seen as relevant to everything from mood symptoms to neurodegenerative disease without…see section ↓
- Claim "mold": not supported by peer-reviewed evidence.see section ↓
- Claim "black mold": mixed in the medical literature.see section ↓
- NPI registry confirms Jonah Yakel as Chiropractor (DC) in Kansas (NPI 1619145026).see section ↓
- Jonah Dallas Yakel shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Jonah Dallas Yakel is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. §65-2871 (Kansas Healing Arts Act)), these advertised activities appear outside Jonah Dallas Yakel's license (including conditions they merely list as ones they treat): CIRS, depression, ADHD.see section ↓
- 18 of 18 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
Claims & evidence
17 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure CIRS.
CIRS
- Supports
- High-quality evidence specifically on Chronic Inflammatory Response Syndrome (CIRS) is limited but not entirely absent. [5][6][7] A recent peer‑reviewed literature review (systematic‑style narrative review) reports 13 published articles (14 studies) on CIRS treatment, including two randomized controlled trials, and concludes that the Shoemaker Protocol is the only treatment with documented clinical efficacy, with statistically significant improvements in objective biomarkers and symptoms across multiple clinical studies. [2] This review supports the perspective that CIRS represents an inflammatory-based illness characterized by innate immune dysregulation following exposure to water‑damaged buildings and that it can be clinically improved with a structured treatment protocol. Additional academic and professional narratives describe CIRS as a sustained innate immune response syndrome with characteristic biomarker abnormalities (e. g. , C4a, TGF‑β1, MMP‑9, low MSH, abnormal visual contrast sensitivity) and transcriptomic signatures such as “molecular hypometabolism,” suggesting a reproducible pattern of immune and metabolic disruption in affected patients. [8] These sources, while not large-scale RCTs or formal guideline statements, provide some empirical support that a definable clinical entity associated with chronic inflammatory responses to biotoxins can be identified and treated within specialized practice models. [3]
- Contradicts
- Mainstream guidelines and major evidence-based bodies do not currently recognize CIRS as an established diagnosis. [1][2] A clinical policy review states explicitly that chronic inflammatory response syndrome is considered an investigational or not clinically proven diagnosis and therefore not medically necessary, noting that it is not recognized as a pathologic entity in major biomedical databases, lacks an ICD coding designation, and has no unifying clinical studies that establish a clear disease entity linking proposed laboratory and environmental findings. [6] This review emphasizes inconsistent definitions, limited large-scale studies, and reliance on single-author narrative reviews that may not have undergone robust peer review. Broader guideline documents on hypertension, parenteral nutrition, and clinical nutrition in inflammatory bowel disease focus extensively on chronic inflammation as a mechanism but do not mention CIRS or endorse it as a distinct syndrome. [3][4][7] Overall, the available high-quality guideline-level evidence either ignores CIRS altogether or explicitly classifies it as unproven, indicating that current evidence is considered too weak, too narrow in scope, or too methodologically limited to support widespread clinical adoption.
- Mainstream view
- The mainstream medical position is that chronic inflammation is a key driver of many diseases, but Chronic Inflammatory Response Syndrome, as defined in Shoemaker-style protocols, is not an established, widely accepted diagnostic entity. [6][7] Major specialty guidelines for cardiovascular disease, parenteral nutrition, and inflammatory bowel disease address chronic inflammatory mechanisms and management without recognizing CIRS as a formal syndrome. [2][3][4] Health-plan and policy reviews explicitly classify CIRS as investigational and not clinically proven, citing the absence of consensus diagnostic criteria across mainstream organizations, lack of ICD coding, and insufficient large, independent, peer‑reviewed trials linking proposed biomarkers and environmental exposures into a validated disease construct. [8] Within functional and integrative medicine circles, CIRS is more often regarded as a real but emerging condition with a growing research base, yet mainstream academic and regulatory bodies continue to treat it as experimental and controversial pending more rigorous, independent, and large-scale evidence. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“#CIRS”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure depression.
depression
No specific health claims of theirs were cross-checked against the literature.
“#depression”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure ADHD.
ADHD
No specific health claims of theirs were cross-checked against the literature.
“#adhd”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Alzheimer's.
Alzheimer's
No specific health claims of theirs were cross-checked against the literature.
“#alzheimers”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure dementia.
dementia
No specific health claims of theirs were cross-checked against the literature.
“#dementia”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure chronic fatigue.
chronic fatigue
No specific health claims of theirs were cross-checked against the literature.
“#chronicfatigue”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure fibromyalgia.
fibromyalgia
No specific health claims of theirs were cross-checked against the literature.
“#fibromyalgia”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Framing mold/CIRS as a broad explanatory model for chronic illness as within their scope of practice.
Framing mold/CIRS as a broad explanatory model for chronic illness
- Supports
- High-quality evidence specifically on Chronic Inflammatory Response Syndrome (CIRS) is limited but not entirely absent. [5][6][7] A recent peer‑reviewed literature review (systematic‑style narrative review) reports 13 published articles (14 studies) on CIRS treatment, including two randomized controlled trials, and concludes that the Shoemaker Protocol is the only treatment with documented clinical efficacy, with statistically significant improvements in objective biomarkers and symptoms across multiple clinical studies. [2] This review supports the perspective that CIRS represents an inflammatory-based illness characterized by innate immune dysregulation following exposure to water‑damaged buildings and that it can be clinically improved with a structured treatment protocol. Additional academic and professional narratives describe CIRS as a sustained innate immune response syndrome with characteristic biomarker abnormalities (e. g. , C4a, TGF‑β1, MMP‑9, low MSH, abnormal visual contrast sensitivity) and transcriptomic signatures such as “molecular hypometabolism,” suggesting a reproducible pattern of immune and metabolic disruption in affected patients. [8] These sources, while not large-scale RCTs or formal guideline statements, provide some empirical support that a definable clinical entity associated with chronic inflammatory responses to biotoxins can be identified and treated within specialized practice models. [3]
- Contradicts
- Mainstream guidelines and major evidence-based bodies do not currently recognize CIRS as an established diagnosis. [1][2] A clinical policy review states explicitly that chronic inflammatory response syndrome is considered an investigational or not clinically proven diagnosis and therefore not medically necessary, noting that it is not recognized as a pathologic entity in major biomedical databases, lacks an ICD coding designation, and has no unifying clinical studies that establish a clear disease entity linking proposed laboratory and environmental findings. [6] This review emphasizes inconsistent definitions, limited large-scale studies, and reliance on single-author narrative reviews that may not have undergone robust peer review. Broader guideline documents on hypertension, parenteral nutrition, and clinical nutrition in inflammatory bowel disease focus extensively on chronic inflammation as a mechanism but do not mention CIRS or endorse it as a distinct syndrome. [3][4][7] Overall, the available high-quality guideline-level evidence either ignores CIRS altogether or explicitly classifies it as unproven, indicating that current evidence is considered too weak, too narrow in scope, or too methodologically limited to support widespread clinical adoption.
- Mainstream view
- The mainstream medical position is that chronic inflammation is a key driver of many diseases, but Chronic Inflammatory Response Syndrome, as defined in Shoemaker-style protocols, is not an established, widely accepted diagnostic entity. [6][7] Major specialty guidelines for cardiovascular disease, parenteral nutrition, and inflammatory bowel disease address chronic inflammatory mechanisms and management without recognizing CIRS as a formal syndrome. [2][3][4] Health-plan and policy reviews explicitly classify CIRS as investigational and not clinically proven, citing the absence of consensus diagnostic criteria across mainstream organizations, lack of ICD coding, and insufficient large, independent, peer‑reviewed trials linking proposed biomarkers and environmental exposures into a validated disease construct. [8] Within functional and integrative medicine circles, CIRS is more often regarded as a real but emerging condition with a growing research base, yet mainstream academic and regulatory bodies continue to treat it as experimental and controversial pending more rigorous, independent, and large-scale evidence. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“#mold”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise CIRS / mold-centered root-cause framing for broad neuropsychiatric and chronic-symptom complaints as within their scope of practice.
CIRS / mold-centered root-cause framing for broad neuropsychiatric and chronic-symptom complaints
- Supports
- High-quality evidence specifically on Chronic Inflammatory Response Syndrome (CIRS) is limited but not entirely absent. [5][6][7] A recent peer‑reviewed literature review (systematic‑style narrative review) reports 13 published articles (14 studies) on CIRS treatment, including two randomized controlled trials, and concludes that the Shoemaker Protocol is the only treatment with documented clinical efficacy, with statistically significant improvements in objective biomarkers and symptoms across multiple clinical studies. [2] This review supports the perspective that CIRS represents an inflammatory-based illness characterized by innate immune dysregulation following exposure to water‑damaged buildings and that it can be clinically improved with a structured treatment protocol. Additional academic and professional narratives describe CIRS as a sustained innate immune response syndrome with characteristic biomarker abnormalities (e. g. , C4a, TGF‑β1, MMP‑9, low MSH, abnormal visual contrast sensitivity) and transcriptomic signatures such as “molecular hypometabolism,” suggesting a reproducible pattern of immune and metabolic disruption in affected patients. [8] These sources, while not large-scale RCTs or formal guideline statements, provide some empirical support that a definable clinical entity associated with chronic inflammatory responses to biotoxins can be identified and treated within specialized practice models. [3]
- Contradicts
- Mainstream guidelines and major evidence-based bodies do not currently recognize CIRS as an established diagnosis. [1][2] A clinical policy review states explicitly that chronic inflammatory response syndrome is considered an investigational or not clinically proven diagnosis and therefore not medically necessary, noting that it is not recognized as a pathologic entity in major biomedical databases, lacks an ICD coding designation, and has no unifying clinical studies that establish a clear disease entity linking proposed laboratory and environmental findings. [6] This review emphasizes inconsistent definitions, limited large-scale studies, and reliance on single-author narrative reviews that may not have undergone robust peer review. Broader guideline documents on hypertension, parenteral nutrition, and clinical nutrition in inflammatory bowel disease focus extensively on chronic inflammation as a mechanism but do not mention CIRS or endorse it as a distinct syndrome. [3][4][7] Overall, the available high-quality guideline-level evidence either ignores CIRS altogether or explicitly classifies it as unproven, indicating that current evidence is considered too weak, too narrow in scope, or too methodologically limited to support widespread clinical adoption.
- Mainstream view
- The mainstream medical position is that chronic inflammation is a key driver of many diseases, but Chronic Inflammatory Response Syndrome, as defined in Shoemaker-style protocols, is not an established, widely accepted diagnostic entity. [6][7] Major specialty guidelines for cardiovascular disease, parenteral nutrition, and inflammatory bowel disease address chronic inflammatory mechanisms and management without recognizing CIRS as a formal syndrome. [2][3][4] Health-plan and policy reviews explicitly classify CIRS as investigational and not clinically proven, citing the absence of consensus diagnostic criteria across mainstream organizations, lack of ICD coding, and insufficient large, independent, peer‑reviewed trials linking proposed biomarkers and environmental exposures into a validated disease construct. [8] Within functional and integrative medicine circles, CIRS is more often regarded as a real but emerging condition with a growing research base, yet mainstream academic and regulatory bodies continue to treat it as experimental and controversial pending more rigorous, independent, and large-scale evidence. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“#mold”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure mold.
mold
- Supports
- No high-quality evidence in the provided index papers supports the standalone claim “mold” as a medical assertion. The listed peer-reviewed papers are unrelated guideline articles on hypertension, nutrition, and inflammatory bowel disease, so they do not provide supportive evidence for a general claim about mold exposure or mold illness . [1][3][4]
- Contradicts
- The claim is too vague to evaluate as written, and the provided index papers do not address mold at all; therefore they neither support nor meaningfully test it . In mainstream medical literature, indoor dampness and visible mold are associated with respiratory symptoms and asthma exacerbation, but broad claims that mold causes nonspecific systemic illness in most people are not established by major guidelines or high-quality trials. [2] Because no mold-specific peer-reviewed index paper was supplied, there is no direct evidence here supporting a strong mold-toxicity claim.
- Mainstream view
- Mainstream medicine recognizes that damp indoor environments and mold can worsen allergies, asthma, and some respiratory symptoms, and remediation of moisture problems is recommended. Broad claims that mold commonly causes chronic multisystem illness are not supported by strong consensus evidence, especially without a clear exposure history, symptom pattern, and objective findings. [1][2][3][4]
“#mold”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure black mold.
black mold
- Supports
- The specific index papers listed by the user are unrelated to black mold, so they provide no direct support for any clinical claim about black mold exposure. High‑quality evidence and major reviews outside this list indicate that damp, moldy indoor environments are associated with increased risk of respiratory symptoms, asthma exacerbations, and other nonspecific upper and lower respiratory complaints, and Stachybotrys chartarum (often called black mold) can contribute as one of many indoor molds. [9][10][12] Consensus documents and epidemiologic studies support an association between damp/moldy buildings and building‑related asthma and upper respiratory disease, though this is not specific to black mold alone. Experimental and mechanistic work shows Stachybotrys chartarum produces potent mycotoxins (macrocyclic trichothecenes and atranones) and other bioactive compounds that can cause inflammation, cytotoxicity, and neurotoxicity in animal and in vitro models, supporting biological plausibility that heavy exposure can be harmful. [11] Case reports and some observational data suggest that very intense exposures, particularly in heavily contaminated environments, may be linked to serious outcomes such as pulmonary hemorrhage in infants, but these data are limited and methodologically weak.
- Contradicts
- The index papers provided do not address mold or mycotoxins and therefore do not contradict or support any specific claim about black mold; they are simply irrelevant to this topic. Multiple high‑quality reviews and public health summaries indicate that current evidence does not support black mold as uniquely dangerous compared with other indoor molds at typical household exposure levels, and there is no proven causal link between ordinary residential black mold exposure and severe systemic disease in otherwise healthy individuals. Reviews of Stachybotrys chartarum and indoor mold exposure emphasize that many studies suggesting severe illness have significant methodological flaws, with no well‑substantiated evidence of serious illness from typical contemporary residential exposure. [10][11][12] Major agencies note that the supposed association between black mold and infant pulmonary hemorrhage remains unproven and that there is no diagnostic test that links specific symptoms directly to Stachybotrys chartarum. [9] Overall, the evidence base for dramatic, specific claims (for example, that any presence of black mold will poison occupants, cause widespread neurologic damage, or uniquely severe chronic illness) is weak, inconsistent, and often based on case reports or uncontrolled observations rather than robust RCTs or large, well‑designed cohort studies.
- Mainstream view
- Mainstream medical and public health opinion is that indoor dampness and visible mold growth are health hazards that should be remediated, but black mold (Stachybotrys chartarum) is not uniquely more dangerous than other indoor molds at typical exposure levels. [9][10][11][12] The accepted view is that molds can trigger or worsen allergic disease, asthma, and nonspecific respiratory and mucosal symptoms, especially in sensitized individuals, children, and those with underlying lung disease or immunocompromise. Serious outcomes such as pulmonary hemorrhage in infants or major neurologic disease have been temporally associated with heavy black mold contamination but remain unproven and are considered rare, requiring unusually intense and prolonged exposure. Major guidelines and public health agencies focus on controlling moisture and removing all molds rather than targeting black mold specifically, and they emphasize that evidence does not support dramatic claims that ordinary household black mold exposure causes systemic toxicity in the general population. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“#blackmold”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure chronic inflammatory response syndrome.
chronic inflammatory response syndrome
- Supports
- High-quality evidence for chronic inflammatory response syndrome (CIRS) as a distinct, validated medical diagnosis is limited and largely consists of narrative reviews and uncontrolled clinical reports rather than large, independent randomized trials or guideline endorsements. [1][2][3][6][13] Reviews and position papers by proponents describe CIRS as a multi-system, multi-symptom illness driven by sustained innate immune activation after exposure to biotoxins such as mold, mycotoxins, bacteria, and other agents in water‑damaged buildings, with proposed biomarkers including C4a, TGF‑β1, MMP‑9, and neuropeptides like MSH and VIP. Some recent peer‑reviewed narrative reviews report that the “Shoemaker protocol” has documented clinical efficacy across a series of small studies and case series, suggesting symptom improvement and normalization of proposed biomarkers in patients labeled with CIRS after biotoxin exposure. Other academic literature on mold and mycotoxins acknowledges that mold exposure can exacerbate chronic inflammatory and immune diseases and may interact with pre‑existing immune dysregulation, supporting the broader concept that environmental exposures, including dampness and molds, can contribute to chronic inflammatory states, though not specifically validating CIRS as a unique syndrome. [14][15] The general concept that chronic inflammation and maladaptive immune responses underlie a wide range of chronic diseases (autoimmune, allergic, metabolic, neurodegenerative) is widely accepted in mainstream immunology and internal medicine, which lends theoretical plausibility to the idea that some individuals may have chronic inflammatory responses to environmental triggers.
- Contradicts
- Major health agencies and mainstream clinical policy documents explicitly state that chronic inflammatory response syndrome is not an established, clinically proven diagnosis and is considered investigational or unproven, with no ICD code, no consensus diagnostic criteria accepted by bodies such as CDC or WHO, and insufficient evidence to support routine clinical use. [3][6][13][14][15] A clinical policy review notes that the condition is not recognized as a pathologic entity in large medical databases and that the systematic health effects of mold exposure, beyond well‑defined allergic and infectious manifestations, are not well understood, emphasizing that available studies are largely from a single clinical group and lack independent replication, robust controls, and large-scale validation. Mainstream toxicology and environmental health experts argue that mycotoxin levels in typical water‑damaged buildings are far below those known to cause systemic toxic effects, and they view claims of widespread systemic biotoxin illness affecting an estimated 25% of the population as unsupported by dose–response data and high‑quality epidemiology. Commentaries from academic and clinical sources describe CIRS and the Shoemaker protocol as controversial and disputed, pointing out that diagnostic panels (HLA‑DR genotyping, extensive cytokine and neuropeptide testing, specialized mycotoxin assays) and multi‑step treatment algorithms are not validated by major guidelines, rely heavily on off‑label medication use, and have not been tested rigorously in randomized controlled trials with independent investigators. [2] While environmental molds and dampness are recognized to cause or exacerbate allergies, asthma, and some respiratory infections, and may contribute to non‑specific symptoms in susceptible individuals, mainstream reviews do not support a specific, unified CIRS diagnosis with defined biomarkers and a proprietary treatment protocol as standard of care.
- Mainstream view
- The mainstream medical position is that chronic inflammatory response syndrome, as defined by Shoemaker and related protocols, is not a formally recognized medical diagnosis, remains highly controversial, and lacks sufficient high‑quality evidence (large independent cohorts, randomized trials, validated biomarkers, and consensus diagnostic criteria) to be accepted into standard practice. [6][13][14][15] Leading health organizations and academic clinicians acknowledge that chronic inflammation is central to many diseases and
“#chronicinflammatoryresponsesyndrome”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure brain health.
brain health
- Supports
- The claim is too vague to evaluate as written because “brain health” is not a specific, testable medical claim. The closest relevant evidence in the indexed papers concerns risk-factor management and mental-health treatment, not a direct general claim that any particular influencer recommendation improves brain health. Evidence-based hypertension management can reduce vascular risk factors that are relevant to brain outcomes such as stroke and vascular cognitive impairment . [1] Major depression treatment guidelines support treating depression because depression itself is associated with impaired functioning and cognitive symptoms, but this is not the same as proving a broad “brain health” intervention . [16]
- Contradicts
- There is no direct peer-reviewed evidence in the provided index list that validates the broad claim “brain health. ” The cannabis umbrella review found a complex risk-benefit profile and does not support a simple positive brain-health claim; rather, it highlights harms and inconsistent evidence across outcomes . [17] The antidepressant umbrella review addresses depression in medically ill patients, not generic brain-health enhancement, so it does not substantiate the claim as stated . [16] The indexed trial records do not provide evidence for the claim either because they are not results papers and are unrelated to brain-health efficacy.
- Mainstream view
- Mainstream medicine does not accept a nonspecific claim of “brain health” without defining the intervention, population, and outcome. Evidence-based clinicians focus on established brain-risk modifiers such as blood pressure control, depression treatment when indicated, avoidance of harmful substance use, sleep, exercise, and vascular risk reduction; among the indexed papers, only hypertension management clearly aligns with a known pathway for preserving brain health through vascular risk reduction . [16][17][1] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“#brainhealth”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure inflammation.
inflammation
No specific health claims of theirs were cross-checked against the literature.
“#inflammation”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure anxiety.
anxiety
No specific health claims of theirs were cross-checked against the literature.
“#anxiety”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure functional medicine.
functional medicine
No specific health claims of theirs were cross-checked against the literature.
“#functionalmedicine”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Using functional medicine branding for broad disease management as within their scope of practice.
Using functional medicine branding for broad disease management
No specific health claims of theirs were cross-checked against the literature.
“#functionalmedicine”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Manipulation
transcript · cited
The post bundles a long list of serious, overlapping conditions into a single hashtag cloud. That is classic reach-maximizing and trust-borrowing: it signals that the creator wants to be seen as relevant to everything from mood symptoms to neurodegenerative disease without actually showing evidence for any one claim. Likely motive: Algorithmic discovery plus broad disease-market capture
“#mold #blackmold #CIRS #chronicinflammatoryresponsesyndrome #brainhealth #inflammation #depression #anxiety #adhd #alzheimers #dementia #functionalmedicine #chronicfatigue #fibromyalgia”
transcript · cited
Tagging functional medicine alongside mold/CIRS, depression, anxiety, ADHD, Alzheimer’s, dementia, chronic fatigue, and fibromyalgia is a broad commercial positioning move. It suggests the page is building a pipeline where vague symptoms get re-labeled as a root-cause syndrome that can later be monetized through consults, testing, and protocols. Likely motive: Positioning for downstream consults, testing, and protocol sales
“#functionalmedicine”
Commerce & grift map
This clip is more of a top-of-funnel disease-dumping post than a monetized checkout page, but the pattern is obvious: pile on fear-laden chronic conditions, then later convert the worried viewer into a consult, protocol, or lab customer. No direct affiliate or lab-sale mechanism is visible here, but the condition list is broad enough to tee up a very profitable 'root cause' funnel.
No FTC-style compensation disclosure
compensationDisclosures · scan
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: none · Likely: Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor · KS license 0105307.
Jonah Yakel presents with a 'Dr.' title in the handle/name, but this clip does not verify an MD/DO license. The bigger issue is that the branding leans into broad internal-disease territory — mold, CIRS, depression, anxiety, ADHD, Alzheimer’s, dementia, chronic fatigue, and fibromyalgia — which is exactly the kind of scope inflation that lets a narrow credential masquerade as general medical authority.
- Chiropractor (DC), Doctor of Chiropractic
Kansas DCs are regulated by the Kansas State Board of Healing Arts. Scope is limited to chiropractic methods for musculoskeletal and nervous-system conditions, not general internal medicine, hormone replacement medicine, or primary disease management.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: medium
Kansas DCs are regulated by the Kansas State Board of Healing Arts. Scope is limited to chiropractic methods for musculoskeletal and nervous-system conditions, not general internal medicine, hormone replacement medicine, or primary disease management.
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
18 of 18 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service CIRS Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service depression Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service ADHD Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Alzheimer's Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service dementia Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service chronic fatigue Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service fibromyalgia Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Framing mold/CIRS as a broad explanatory model for chronic illness Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| CIRS / mold-centered root-cause framing for broad neuropsychiatric and chronic-symptom complaints Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service mold Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service black mold Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service chronic inflammatory response syndrome Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service brain health Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service inflammation Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service anxiety Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service functional medicine Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Implying expertise in systemic and neuropsychiatric disease through condition tagging Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Using functional medicine branding for broad disease management Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
Sources: Board regulatory language (Firecrawl) (official)
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (drjonahyakel.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission BvswIj3HRHr5ohtWUMTwo
Fight disinformation
Log a public thread where Jonah Dallas Yakel is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Jonah Dallas Yakel's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/BvswIj3HRHr5ohtWUMTwo. White-coat charisma isn't evidence.
Full DTMB scan on Jonah Dallas Yakel: https://drtrustmebro.com/analyze/BvswIj3HRHr5ohtWUMTwo
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We email a public contact address from their site so Jonah Dallas Yakel can review this dossier and dispute anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Jonah Dallas Yakel, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Jonah Dallas Yakel. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: 0o8IxZAbZXTO291VUoiW9
- Wall entry: /influencer/0o8IxZAbZXTO291VUoiW9
- Analysis ID: BvswIj3HRHr5ohtWUMTwo
- Source: https://www.tiktok.com/@drjonahyakel/video/7218238747031194923
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [2] ASPEN-FELANPE Clinical Guidelines.
- [3] ESPEN guideline: Clinical nutrition in inflammatory bowel disease.
- [4] When Is Parenteral Nutrition Appropriate?
- [5] Evidence of robust memory T‐cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)
- [6] Chronic inflammatory response syndrome: a review of ... - PMC
- [7] Inflammation in complex regional pain syndrome
- [8] Biomarkers over Time: From Visual Contrast Sensitivity ... - PMC
- [9] Update on Stachybotrys chartarum—Black Mold Perceived as ...
- [10] Facts About Stachybotrys chartarum | Mold
- [11] Stachybotrys chartarum: cause of human disease or media ...
- [12] Indoor mold, toxigenic fungi, and Stachybotrys chartarum
- [13] Microbial ‘Old Friends’, immunoregulation and stress resilience
- [14] No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases
- [15] Chronic inflammatory systemic diseases
- [16] Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-Analysis.
- [17] Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
- [18] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes.